Agile Therapeutics to Host Second Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, August 11, 2020

Rhea-AI Summary

Agile Therapeutics (Nasdaq: AGRX) will report its Q2 2020 financial results on August 11, 2020, after market close. A live conference call will follow at 4:30 p.m. ET to discuss the results and provide updates. Interested investors can join via phone or through a live webcast available on the company's Investor Relations page. Agile focuses on women's healthcare, aiming to address unmet health needs, particularly with its transdermal contraceptive product, Twirla®. For more details, visit www.agiletherapeutics.com.

Live Conference Call and Webcast at 4:30 p.m. ET

PRINCETON, N.J., July 21, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced it will report second quarter 2020 financial results after the market close on Tuesday, August 11, 2020. Following the release, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss the Company’s financial results and provide a business update.

Investors interested in listening to the conference call may do so by dialing (877) 407-2991 for domestic callers or (201) 389-0925 for international callers. A live webcast will be available in the Events and Presentations section of the Investor Relations page at https://ir.agiletherapeutics.com/events-and-presentations/, or by clicking here.

Please log in approximately 10 minutes prior to the scheduled start time. The archived webcast will be available in the Events and Presentations section of the company's website.

About Agile Therapeutics, Inc.
Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.

Follow Agile on LinkedIn and Twitter: @AgileTher.

Source: Agile Therapeutics

Contact: 
Matt Riley
Investor Relations
mriley@agiletherapeutics.com

FAQ

When is Agile Therapeutics expected to release its Q2 2020 financial results?

Agile Therapeutics will release its Q2 2020 financial results on August 11, 2020, after market close.

What time will the Agile Therapeutics conference call be held?

The conference call will be held at 4:30 p.m. ET on August 11, 2020.

How can investors participate in the Agile Therapeutics conference call?

Investors can participate by dialing (877) 407-2991 for domestic calls or (201) 389-0925 for international calls. A webcast will also be available online.

What is the focus of Agile Therapeutics?

Agile Therapeutics is a women's healthcare company dedicated to providing contraceptive options, including its product Twirla®, which is a transdermal contraceptive patch.